4.65 USD
▲+0.01+0.22%
盘后 4.85 +4.30%
2026-09-15
市值
$105.09M
市盈率
—
EPS
-1.09
股息率
—
52 周区间
3.71 – 7.75
成交量
215.17K
Beta
0.62
目标价
15.21
52W 低 3.7152W 高 7.75
价格走势
公司简介
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. The company develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase 2 trial for use in the treatm...